NCR3LG1 (B7-H6) is a potential prognostic factor for bladder cancer patients

References

• Alfred Witjes, J., et al., 2017. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. European urology, 71 (3), 462–475.
   PubMed Web of Science ®Google Scholar
• Antoni, S., et al., 2017. Bladder cancer incidence and mortality: a global overview and recent trends. European urology, 71 (1), 96–108.
   PubMed Web of Science ®Google Scholar
• Babjuk, M., et al., 2017. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. European urology, 71 (3), 447–461.
   PubMed Web of Science ®Google Scholar
• Barton, M.K., 2013. High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer. CA: a cancer journal for clinicians, 63, 371–372.
   PubMed Web of Science ®Google Scholar
• Bindea, G., et al., 2013. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity, 39 (4), 782–795.
   PubMed Web of Science ®Google Scholar
• Brandt, C.S., et al., 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. The journal of experimental medicine, 206 (7), 1495–1503.
   PubMed Web of Science ®Google Scholar
• Ceeraz, S., Nowak, E.C., and Noelle, R.J., 2013. B7 family checkpoint regulators in immune regulation and disease. Trends in immunology, 34 (11), 556–563.
   PubMed Web of Science ®Google Scholar
• Chamie, K., et al., 2013. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer, 119 (17), 3219–3227.
   PubMed Web of Science ®Google Scholar
• Chavan, S., et al., 2014. International variations in bladder cancer incidence and mortality. European urology, 66 (1), 59–73.
   PubMed Web of Science ®Google Scholar
• Chen, X.J., et al., 2014. B7-H6 protein expression has no prognostic significance in human gastric carcinoma. Pathology oncology research: POR, 20 (1), 203–207.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2018. The B7 family member B7-H6: a new bane of tumor. Pathology oncology research : POR, 24 (4), 717–721.
   PubMed Web of Science ®Google Scholar
• Collins, M., Ling, V., and Carreno, B.M., 2005. The B7 family of immune-regulatory ligands. Genome biology, 6 (6), 223.
   PubMed Web of Science ®Google Scholar
• Fiegler, N., et al., 2013. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells. Blood, 122 (5), 684–693.
   PubMed Web of Science ®Google Scholar
• Flaig, T.W., et al., 2018. NCCN guidelines insights: bladder cancer, version 5.2018. Journal of the national comprehensive cancer network, 16, 1041–1053.
   PubMed Web of Science ®Google Scholar
• Gao, H., et al., 2018. Increased KIF4A expression is a potential prognostic factor in prostate cancer. Oncology letters, 15 (5), 7941–7947.
   PubMed Web of Science ®Google Scholar
• Gentles, A.J., et al., 2015. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature medicine, 21 (8), 938–945.
   PubMed Web of Science ®Google Scholar
• He, Y.T., et al., 2018. [Incidence and mortality of bladder cancer in China, 2014]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 40 (9), 647–652.
   PubMedGoogle Scholar
• Jiang, T., et al., 2017. High expression of B7-H6 in human glioma tissues promotes tumor progression. Oncotarget, 8 (23), 37435–37447.
   PubMedGoogle Scholar
• Kaifu, T., et al., 2011. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Cellular and molecular life sciences : CMLS, 68 (21), 3531–3539.
   PubMed Web of Science ®Google Scholar
• Li, C., et al., 2014. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis. Biochemical and biophysical research communications, 446 (4), 1047–1052.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2018. Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity. Cell stem cell, 23 (2), 181–192 e5.
   PubMed Web of Science ®Google Scholar
• Montie, J.E., et al., 2009. Bladder cancer. Journal of the national comprehensive cancer network : JNCCN, 7 (1), 8–39.
   PubMed Web of Science ®Google Scholar
• Ni, L., and Dong, C., 2017. New B7 family checkpoints in human cancers. Molecular cancer therapeutics, 16 (7), 1203–1211.
   PubMed Web of Science ®Google Scholar
• Petrovich, Z., et al., 1998. Management of carcinoma of the bladder. American journal of clinical oncology, 21 (3), 217–222.
   PubMed Web of Science ®Google Scholar
• Priceman, S.J., et al., 2018. Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA + metastatic prostate cancer. Oncoimmunology, 7 (2), e1380764.
   PubMed Web of Science ®Google Scholar
• Semeraro, M., et al., 2015. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Science translational medicine, 7 (283), 283ra55–283ra55.
   PubMedGoogle Scholar
• Siegel, R.L., Miller, K.D., and Jemal, A., 2019. Cancer statistics. CA: a cancer journal for clinicians, 69, 7–34.
   PubMed Web of Science ®Google Scholar
• Svatek, R.S., et al., 2014. The economics of bladder cancer: costs and considerations of caring for this disease. European urology, 66 (2), 253–262.
   PubMed Web of Science ®Google Scholar
• Textor, S., et al., 2016. The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells. Oncoimmunology, 5 (7), e1116674.
   PubMed Web of Science ®Google Scholar
• Yeung, C., Dinh, T., and Lee, J., 2014. The health economics of bladder cancer: an updated review of the published literature. Pharmacoeconomics, 32 (11), 1093–1104.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2014. B7-H6 expression in non-small cell lung cancers. International journal of clinical and experimental pathology, 7 (10), 6936–6942.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., et al., 2015. B7-H6 expression correlates with cancer progression, and patient's survival in human ovarian cancer. International journal of clinical & experimental pathology, 8, 9428–9433.
   PubMed Web of Science ®Google Scholar